BEMLAYOH

What this means for you

Approved and waiting on proof of use. It will register unless the applicant drops it, and its 27 Jan 2026 filing date already counts against anyone who files later.

Record

Serial number

99617688

Mark type

Stylized text

Filed

27 Jan 2026

Published for opposition

10 Mar 2026

Attorney of record

John R. Rudolph

Goods and services

• Class 005 — Pharmaceuticals: Pharmaceutical preparations, namely, pharmaceutical preparations for the treatment of alopecia, Alzheimer’s disease, atopic dermatitis, autoimmune diseases and disorders, blood diseases and disorders, bone and skeletal diseases and disorders, cancer, cardiovascular diseases, central nervous system diseases and disorders, cluster headaches, Coronavirus disease, Crohn’s disease, dementia, dermatological diseases and disorders, diabetes, dyslipidemia, endocrine diseases and disorders, fibromyalgia, gastrointestinal diseases and disorders, headaches, hearing loss, heart failure, inflammation and inflammatory diseases and disorders, inflammatory bowel disease, kidney diseases and disorders, liver diseases and disorders, lupus, mental disorders, metabolic diseases and disorders, migraines, multiple sclerosis, neurodegenerative diseases and disorders, neurological disorders, obesity, obstructive sleep apnea, osteoarthritis, pain, Parkinson’s disease, peripheral arterial disease, Psoriasis, Psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, vascular diseases

Owner

• Eli Lilly and Company, Indianapolis, IN, US
• Eli Lilly and Company, Indianapolis, IN, US

Prosecution history

• 10 Mar 2026 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
• 10 Mar 2026 — PUBLISHED FOR OPPOSITION
• 04 Mar 2026 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
• 13 Feb 2026 — APPROVED FOR PUB - PRINCIPAL REGISTER
• 12 Feb 2026 — ASSIGNED TO EXAMINER
• 27 Jan 2026 — APPLICATION FILING RECEIPT MAILED
• 27 Jan 2026 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
• 27 Jan 2026 — NEW APPLICATION ENTERED